Related Articles
CIP-36, a novel topoisomerase II-targeting agent, induces the apoptosis of multidrug-resistant cancer cells in vitro
HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway
COMBINATIVE GROWTH-INHIBITORY EFFECTS OF INTERFERON-ALPHA AND DOXORUBICIN ON MULTIDRUG-RESISTANT TUMOR-CELL LINES
Effect of CIK on multidrug‑resistance reversal and increasing the sensitivity of ADR in K562/ADR cells
Critical involvement of the α(1,2)-fucosyltransferase in multidrug resistance of human chronic myeloid leukemia